Adaptive changes in the responsiveness of adrenergic receptors are thought to be involved in the pathology and/or therapeutic treatment of a variety of disease states, ranging from cardiovascular and pulmonary to neuropsychiatric. Similar changes have been shown to occur in isolated cells in culture, where the cellular and molecular mechanisms involved can be more easily investigated. Exposure of mammalian cells in culture to catecholamines or other adrenergic receptor agonists leads to desensitization of beta-adrenergic receptors and their coupling to adenylate cyclase and to desensitization of alpha1-adrenergic receptors and their coupling to polyphosphoinositide turnover. Recent studies indicate that regulatory interactions also occur between receptors coupled to different signal transduction mechanisms. The proposed studies are aimed at understanding the mechanisms involved in these changes in adrenergic receptor responsiveness, with an emphasis on the likely involvement of protein phosphorylation. Studies of beta-adrenergic receptor regulation will focus on 1321N1 human astrocytoma cells. Studies of alpha1-adrenergic receptor regulation will focus on DDT1 MF-2 hamster smooth muscle cells. Regulatory interactions will be studied in both cell lines. 1) The apparent desensitization of alpha1-adrenergic receptors will be further characterized using approaches similar to those applied previously to beta-adrenergic receptor desensitization, including studies of specificity, guanine nucleotide-binding protein involvement, and receptor internalization. 2) The ability of drugs activating different receptors to cause translocation of beta-adrenergic receptor kinase and protein kinase C will be determined. 3) Inhibitors of protein kinases will be used to directly determine whether phosphorylation is required for desensitization and elucidate the site(s) of involvement of phosphorylation in response regulation. 4) The mechanisms of agonist-induced changes in receptor binding properties measured on intact cells and their relationship to receptor internalization and phosphorylation will be further investigated. 5) The occurrence, significance, and molecular mechanism(s) of sensitization of adenylate cyclase activity by activators of polyphosphoinositide turnover and by activators of protein kinase C will be further investigated.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
7R01GM034500-06
Application #
3285626
Study Section
Pharmacology A Study Section (PHRA)
Project Start
1989-06-01
Project End
1992-11-30
Budget Start
1989-06-01
Budget End
1989-11-30
Support Year
6
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Nebraska Medical Center
Department
Type
Schools of Medicine
DUNS #
City
Omaha
State
NE
Country
United States
Zip Code
68198
Hague, Chris; Chen, Zhongjian; Pupo, Andre S et al. (2004) The N terminus of the human alpha1D-adrenergic receptor prevents cell surface expression. J Pharmacol Exp Ther 309:388-97
Prinster, Steven C; Schulte, Nancy A; Collins, Megan R et al. (2003) Up-regulation of alpha1B-adrenergic receptors with defects in G protein coupling: ligand-induced protection from receptor instability. Mol Pharmacol 64:1126-35
Toews, Myron L; Prinster, Steven C; Schulte, Nancy A (2003) Regulation of alpha-1B adrenergic receptor localization, trafficking, function, and stability. Life Sci 74:379-89
Wang, J; Wang, L; Zheng, J et al. (2000) Identification of distinct carboxyl-terminal domains mediating internalization and down-regulation of the hamster alpha(1B)- adrenergic receptor. Mol Pharmacol 57:687-94
Cerutis, D R; Nogami, M; Anderson, J L et al. (1997) Lysophosphatidic acid and EGF stimulate mitogenesis in human airway smooth muscle cells. Am J Physiol 273:L10-5
Bird, K S; Anderson, J L; Toews, M L (1997) Modulation of alpha1B-adrenoceptor expression by agonist and protein kinase inhibitors. Eur J Pharmacol 340:267-75
Wang, J; Zheng, J; Anderson, J L et al. (1997) A mutation in the hamster alpha1B-adrenergic receptor that differentiates two steps in the pathway of receptor internalization. Mol Pharmacol 52:306-13
Zhu, S J; Hatcher, L I; Brown 3rd, J C et al. (1996) Effects of hypertonic sucrose and potassium depletion on the binding properties of beta and alpha 1 adrenergic receptors measured on intact cells. Recept Signal Transduct 6:131-40
Zhu, S J; Cerutis, D R; Anderson, J L et al. (1996) Regulation of hamster alpha 1B-adrenoceptors expressed in Chinese hamster ovary cells. Eur J Pharmacol 299:205-12
Hoffman, J; Whittle, S; Toews, M (1996) Modulation of cyclic AMP accumulation in glial cells by exogenous phospholipase C. J Lipid Mediat Cell Signal 13:51-62

Showing the most recent 10 out of 27 publications